Cervical ripening in humans: Potential roles of estrogen, progesterone, and insulin-like growth factor-I - 11/09/11
Abstract |
OBJECTIVE: During pregnancy in humans a gradual connective tissue remodeling takes place in the cervix. The aim of this study was to examine a possible relationship between the action of gonadal steroids and growth factors and the biochemically identifiable changes in connective tissues during cervical ripening. STUDY DESIGN: Cervical biopsy specimens and serum samples were taken from 20 term pregnant and 20 nonpregnant menstruating women. Estrogen receptors and progesterone receptors were measured with enzyme immunoassays. The messenger ribonucleic acid levels for estrogen receptors, progesterone receptors, and insulin-like growth factor-I were determined by solution hybridization with human complementary deoxyribonucleic acid probes. The concentration of collagen and its solubility by pepsin digestion were measured. Statistical evaluations were done with the Student t test. RESULTS: In term pregnancy the estrogen receptor level decreased to 14% and the progesterone receptor level to 24% of nonpregnant levels (p < 0.001 and p < 0.01). The insulin-like growth factor-I messenger ribonucleic acid level increased 400% (p < 0.01), whereas the messenger ribonucleic acid levels for estrogen receptors and progesterone receptors were unchanged. The changes coincided with a twofold decrease in collagen concentration (hydroxyproline) and a twofold increase in collagen solubility. CONCLUSION: Estrogen receptors and progesterone receptors are present in human cervix. A significant down-regulation of estrogen receptors and progesterone receptors and a fourfold increase in the insulin-like growth factor-I messenger ribonucleic acid level were registered in term pregnant cervix. These findings coincided with the remodeling of the cervical connective tissue. (AM J OBSTET GYNECOL 1996;174:1065-71.)
Le texte complet de cet article est disponible en PDF.Keywords : Estrogen receptor, progesterone receptor, messenger ribonucleic acid, insulin-like growth factor-I, cervical ripening
Plan
From the Divisions of Obstetric and Gynecologya and Reproductive Endocrinology,b Karolinska Hospital, the Department of Woman and Child Health, Karolinska Institute, and the Department of Physiological Chemistry, University of Lund.c |
|
Supported by grants No. 03X-3972 and 04X-9508 from the Swedish Medical Research Council and by Karolinska Institutets Fonder. |
|
Reprint requests: Ylva Stjernholm, MD, Department of Obstetrics and Gynecology, Karolinska Hospital, S-171 76, Stockholm, Sweden. |
|
0002-9378/96 $5.00 + 0 6/1/68368 |
Vol 174 - N° 3
P. 1065-1071 - mars 1996 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?